G Medical Innovations Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- G Medical Innovations's estimated annual revenue is currently $8.3M per year.
- G Medical Innovations's estimated revenue per employee is $251,000
- G Medical Innovations's total funding is $30.8M.
- G Medical Innovations has 33 Employees.
- G Medical Innovations grew their employee count by 14% last year.
- G Medical Innovations currently has 1 job openings.
What Is G Medical Innovations?
G Medical Innovations (ASX: GMV) is a next-generation mobile health company. We believe in transforming personal healthcare by developing innovative mobile-health solutions that provide comprehensive, medical-grade diagnostics using remote and personalized platforms. Founded in 2014, we strive to increase healthcare efficiency, empower physicians, caregivers and consumers, and improve personal quality of life by providing a higher level of healthcare that is accessible to more people worldwide. G Medical Innovations operates in the USA, Europe, China, the Middle East and Australia. The Company has established a new and advanced manufacturing site in China, Guangdong, and operates a wholly owned subsidiary, G Medical Diagnostic Services, Inc. that provides arrhythmia monitoring and diagnostics in the USA. The G Medical PRIZMA offering is an innovative FDA cleared/CE approved medical smartphone case that transforms any smartphone into a medical monitoring and diagnostic device. With PRIZMA, users can independently manage their health by continuously measuring, monitoring and sharing vital signs with caregivers and loved ones. A further offering in development, the Vital Monitoring System (VSMS) with G Medical Patch (GMP) is a health monitoring solution that provides accurate diagnostics in real-time and offers a heightened level of care for patient monitoring in all healthcare settings. This modular, easy-to-use, clinical grade solution utilizes patented wireless technologies, proprietary information technology and service platforms. The solutions can enhance patient care and help healthcare providers increase efficiency, decrease liability and reduce the number of readmissions. (Note: The GMP/VSMS device is currently under CE and FDA evaluation and it is not for sale in the US)keywords:N/A